Loading stock data…

© 2026 Whystock · Bureau7 LLC. Intelligent Financial Insights.

Not financial advice. Data may be delayed. Use at your own risk.

Stock Glossary Popular Stocks Stock ScreenerPrivacy Terms

Why GKOS? Glaukos Corporation Analysis, Price & AI Insights | Whystock

GKOS

$140.22-3.45 (-2.40%)

Market ClosedLast close May 1

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

to

No data available for this range. Intraday data may be limited by the exchange.